HCWB Stock Analysis: Buy, Sell, or Hold?
HCWB - HCW Biologics Inc. Common Stock
$2.18
0.06 (2.83%)
▲
5d:
-18.66%
30d:
-24.31%
90d:
-15.5%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 17, 2026
0d
Get Alerted When HCWB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: HCWB is down 18.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: HCWB is down 18.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: HCWB is currently trading at $2.18, which is considered oversold relative to its 30-day fair value range of $2.68 to $3.96.
Technical Outlook: Technically, HCWB is in a strong uptrend. Immediate support is located at $2.05, while resistance sits at $3.67.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $30.00 (+1276.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HCWB is in a strong uptrend. Immediate support is located at $2.05, while resistance sits at $3.67.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $30.00 (+1276.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.68 -
$3.96
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1276.1% below Wall St target ($30.00)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.68 -
$3.96
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.05
Resistance Level
$3.67
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.83
Wall Street Target
$30.00
(+1276.1%)
Revenue Growth (YoY)
129080.7%
Profit Margin
-34.7%
Share & Embed Analysis
Last updated: August 23, 2026 7:51 PM ET
Data refreshes hourly during market hours. Next update: 8:51 PM
Data refreshes hourly during market hours. Next update: 8:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HCWB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 66 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 41 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 27 SELL |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 41 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 49 HOLD |
